eNauka - pregled
Pregled prema Autor Chong, LO
Prikaz rezultata 1 do 1 od 1
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2023 | HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome | Tobias, Joshua; Kundi, Michael; Garner-Spitzer, E; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran G   ; Petrovic, Z; Nagarkar, R; Chawla, T; Chong, LO;
Nixon, B; Yavrom, S; Ede, NJ; Wiedermann, Ursula;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |